Lauren Otsuki

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA.

NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.

Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA.

Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA .

GLO Pharma, Inc. is a skincare company that focuses on activating the skin's natural ability to plump, brighten, firm, and combat dryness. The company is based in Carlsbad, CA. The company offers daily regimens powered by their extraordinary intides™ to reveal a brighter, healthier, and more even-toned look while defending against UV, pollution, and blue light damage. The company's products include a light-textured mineral sunscreen that visibly firms, smooths, and softens the skin. GLO Pharma also offers a lip enhancing and plumping treatment with groundbreaking delivery technology, as well as a restorative cream that firms, boosts radiance, soothes, and nourishes the skin. GLO Pharma was founded in 2018 by Lauren Otsuki, Scott L. Glenn, and Vimla Black-Gupta. Vimla Black-Gupta has been the CEO since 2018.